|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Fibrinogen Activity, Clauss
Test Code461
CPT Codes
85384
Preferred Specimen
1 mL frozen plasma collected in a 3.2% sodium citrate (light blue-top) tube
Minimum Volume
0.5 mL
Other Acceptable Specimens
Minimum: 4.5 mL whole blood collected in a 3.2% sodium citrate (light blue-top) tube
Instructions
Please submit a separate, frozen vial for each special coagulation assay ordered.
Platelet-poor plasma: Centrifuge light blue-top tube 15 minutes at approx. 1500 g within 60 minutes of collection. Using a plastic pipette, remove plasma, taking care to avoid the WBC/platelet buffy layer and place into a plastic vial. Centrifuge a second time and transfer platelet-poor plasma into a new plastic vial. Plasma must be free of platelets (<10,000/mcL). Freeze immediately and ship on dry ice.
Platelet-poor plasma: Centrifuge light blue-top tube 15 minutes at approx. 1500 g within 60 minutes of collection. Using a plastic pipette, remove plasma, taking care to avoid the WBC/platelet buffy layer and place into a plastic vial. Centrifuge a second time and transfer platelet-poor plasma into a new plastic vial. Plasma must be free of platelets (<10,000/mcL). Freeze immediately and ship on dry ice.
Transport Container
Plastic vial
Transport Temperature
Plasma: Frozen
Whole blood: Room temperature
Whole blood: Room temperature
Specimen Stability
Plasma
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 30 days
Whole blood
Room temperature: 24 hours
Refrigerated: 24 hours
Frozen: Unacceptable
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 30 days
Whole blood
Room temperature: 24 hours
Refrigerated: 24 hours
Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Clotted specimens
Methodology
Photometry/Optical, Clauss
Setup Schedule
Monday-Saturday Night
Report available: Next Day
Report available: Next Day
Limitations
Expected impact by therapeutic levels (potential interference depends upon drug concentration): Warfarin: no effect; Heparin (UFH or LMWH): UFH-no effect, LMWH-normal to falsely low; Dabigatran or Argatroban (Thrombin Inhibitors): no effect or falsely low; Rivaroxaban or Apixaban (Factor Xa Inhibitors): no effect.
Reference Range
175-425 mg/dL
Clinical Significance
Fibrinogen is essential for the formation of a blood clot. Deficiency can produce mild to severe bleeding disorders.